Lessons on Ethical Decision Making from the Bioscience Industry

Mackie and colleagues performed over 100 interviews with managers and executives at 13 bioscience companies to learn about bioindustry ethics from their perspective

Finding balance : an evaluation governance model to ease tension between independence and inclusion

Includes abstract in FrenchPractitioners and theorists have documented the benefits of user engagement and participation in evaluation and, at the same time, the value of neutral and impartial evaluative evidence. Yet producing both an independent and inclusive evaluation is a leading challenge in our field. In this practice note, we present one solution. We describe the design of an evaluation governance structure that was used to find balance between these two themes. We also identify key elements of this experience and present these for adaptation by others, given appropriate tailoring. We have documented our experience as we believe that governance provides currently uncharted potential for this discipline spanning challenge.Les spécialistes et les théoriciens ont documenté les avantages de la participation des utilisateurs en évaluation et, de la même façon, la valeur dedonnées d’évaluation neutres et impartiales. Il reste que réaliser une évaluation aussi indépendante qu’inclusive est encore un défi de taille dans notre domaine. Dans la présente note de pratique, nous présentons une solution. Nous décrivons le design d’une structure d’évaluation de la gouvernance qui a servi à trouver un équilibre entre les deux thèmes. Nous nommons aussi les éléments clés de cette expérience et expliquons comment ils peuvent être adaptés pour répondre à des besoins particuliers. Nous avons documenté notre expérience puisque nous croyons que la gouvernance est une avenue prometteuse pour relever ce défi qui touche de nombreuses disciplines

Guidance for reconciling patent rights and disclosure of findings at scientific meetings

Open collaboration and sharing of information among scientists at scientific meetings can foster innovation and discovery. However, such sharing can be at odds with potential patenting and commercialization objectives. This tension may be mitigated if certain procedures are followed in the context of scientific meetings. The article first discusses what makes a scientific finding patentable and then sets out four specific patent issues for scientists to consider before attending a scientific meeting and sharing their research. Finally, it provides recommendations on how scientists can best protect their intellectual property rights while sharing information at scientific meetings